Dilip Surana led Microlabs Limited Wins peoples heart, voted as Best Company to work for at Pharma Leaders 2016 annual power brand Awards.

Dilip Surana led Microlabs Limited Wins peoples heart, voted as Best Company to work for at Pharma Leaders 2016 annual power brand Awards.

Microlabs Limited voted by the jury members of the Network 7 Media Group’s annual pharmaceutical power brand awards in the category of Best Company to work for under the selection process of strong & robust HR policy aimed at building a world-class community of pharma professionals.

Microlabs received top recognition when the visionary CMD of Microlabs  Dilip Surana received the coveted award at the glittering annual award ceremony of Pharma Leaders Power Brand awards considered to be most credible & prestigious. The Trophy & Citations was received from the hands of Dr. Mukesh Batra, Chairman, Dr Batras & satya brahma, chairman & editor-in-chief, pharma leaders group where more than 400 industry leaders were present on friday, 23rd december 2016 at hotel sahara star.The set of 40 awards ware conferred to the top leaders & companies. Nation’s top healthcare leaders, pharma experts, policy makers, renowned doctors, social activists, bureaucrats & professionals of the Indian pharmaceutical & healthcare leaders assembled to witness the 9th annual pharmaceutical leadership summit & pharma Leaders business leadership awards 2016 organised by Network 7 Media Group’s Pharmaleaders, asia’s most analytical news media in healthcare communications

DILIP-SURANA-_MICRO-LABS

With more than 9000 dedicated employees, 20 marketing divisions, 14 oral formulation plants with a strong R & D facility, the institution of Microlabs’s landmark & inspiring “Micro’s Performance Award”has been very exemplary. Indeed the employees continue to work as a one family & one team making Microlabs as India’s most respected pharma company with a formidable domestic marketing & strong export house. The growth of Microlabs has also been consistent over the last few years  & with among the top 10 companies like Cipla with  (20%), Mankind (21%), Alkem (28%), Macleods (30%), Lupin (24%) and Aristo (38%) grew faster &  Glenmark with  (26%), Micro labs (20%) and IPCA (27%) thus outpaced the market. Today Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centres that are at par with international standards. All this, robustly backed by a strong distribution network and path-breaking research work has placed us amongst India’s fast growing transnational healthcare organizations.

Ranking 14th among prescriptions (as per SMSRC May 16′ )and 19th in sales (as per AWACS MAT May’16) , Micro’s brand portfolio includes some of the topmost brands in various specialties like Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain, etc. Amidst our proud achievers is Dolo, an award-winning brand highly prescribed for fever management.The company is also at the forefront in social contribution, striving to be a model corporate citizen in terms of Environmental Protection & Social Initiatives with significant contributions in the areas of education and health. Micro Labs is poised to achieve unparalleled status in the global pharmaceutical industry. Backed by a profound and resolute vision, we now have our eyes set on attaining the $1 billion mark by 2020.

The Jury Members strongly believes that Dilip Surana’s visionary leadership integrates the task orientation style and people orientation style of leadership in a qualitatively new level of performance. The Company has made people perform tasks because they are happy to do them as they are inspired by the vision of building a successful healthcare empire. Under Mr. Dilip Surana’s visionary leadership,  the entire workforce showed exceptional results and made them perform beyond their imagined limitations. They are  happy not only because their leader is the best but because they have become their best selves because of their leader. The strong 9000 employees bear testimony of Company’s vision that  “people are the main priority at our establishment. Company’s people are essential to Company’s success. Company’s focus on building their capabilities, and aim to support and empower them to be the best they can be. You have attracted and retained the most talented people by investing in training, development, support, and learning opportunities. You rightfully realize that all the technologies and facilities amount to nothing in the hands of an unskilled employee. This reason alone motivates you to provide the best of opportunities and work conditions to Company’s dedicated members. As a progressive healthcare company, helping Company’s employees stay safe, healthy and productive is a priority.

Nation’s top healthcare leaders, pharma experts, policy makers, renowned doctors, social activists, bureaucrats & professionals of the Indian pharmaceutical & healthcare leaders assembled to witness the 9th annual pharmaceutical leadership summit & pharma Leaders business leadership awards 2016 organised by Network 7 Media Group’s Pharmaleaders, asia’s most analytical news media in healthcare communications. The theme of the Summit India@70, was presented by Annaswamy Vaidheesh, Managing Director – India & Vice President South Asia, GSK Pharmaceuticals India. Mr. Krishnakumar Subramaniam, Vice President, Business Development, India, Africa & Middle East, Glenmark Pharmaceuticals Ltd gave an opening Address & moderated the summit analyzing the speakers viewpoint.Satya Brahma,Chairman & Editor-In-Chief – Pharma Leaders Group in his opening address said “the change of guard in America with Donald Trump becoming US president, the impact of healthcare/pharma business will have a significant impact as Trump win might mean opportunities for Indian pharma.Trump had proposed to lift entry barriers for drug makers that offer safe, reliable and cheaper products. India contributes to nearly a third of all drugs sold in the US and this is unlikely to change for now, given the thrust of both Democratic and Republican parties on affordable health care. The US market will, however, continue to see pricing pressure as a result of consolidation of hospitals and insurance companies”. Increasing focus on Patients safety & concerns by hospitals & pharma companies will be key to healthcare innovations said Satya Brahma. The other notable speakers included Mr.Rajendra Pratap Gupta, Policy Maker, Researcher, & advisor to  Minister of Health & Family Welfare , Govt. of India addressed on “Digital Healthcare Innovations – Challenges & Opportunities”. The focus on healthcare delivery was evident as Health care in rural India– How technology can be leveraged for improving health care in Rural India was presented by Mayank Handhi, Social Activist in a interactive debate with Satya Brahma of Pharma Leaders. Dr. Manoj Khanna, Founder and Chairman, Enhance Clinics, Globally renowned Hair Transplant & Cosmetic Surgeon spoke on “Cosmetic Surgery Industry in India – Achi Din kya Aayenge?”. Vipin Pathak, Co- Founder & CEO, Care 24 addressed on Elder Care: Changing landscape, India and global. The highlight of the Summit at Pharma Leaders 2016 debate was on panel discussion moderated by Satya Brahma where top minds of the medical profession & healthcare addressed on “Is healthcare a commodity or a basic human need?”. The esteemed members of the panel discussion were Dr. Kishore Kumar, Consultant Neonatologist, Chairman,Cloudnine Hospital,Dr. Sudhansu Bhattacharyya, Head of Department of Cardiac Thoracic Surgery,  Bombay Hospital,Dr. Mudit Saxena, Group CEO Care Hospitals, Anand Garg, Former Chief Executive Officer, Seven Hills Health,Dr. Manoj Khanna, Chairman, Enhance Clinics,Dr. Debraj Shome, facial plastic surgeon and director, The Esthetic Clinics,Chandrashekhar Pandey – Founder and COO at Smile Merchants,Dr. Mannan Gandhi, Founder, The Integral Ayurveda,Rushi Trivedi – Founding Director & CEO at Smile Merchants

Chandrakant Rathi of Advanced Enzyme Technology to receive the prestigious “Biotech Leader of the Decade” at Pharma Leaders 2016 Annual Power Brand Awards

Chandrakant Rathi of Advanced Enzyme Technology to receive the prestigious “Biotech Leader of the Decade” at Pharma Leaders 2016 Annual Power Brand Awards

 The veteran entrepreneur led Advanced Enzyme as a global leader in healthcare & nutrition & Bio Processing, 400+ proprietary products developed from 60 indigenous enzymes made Rathi as undisputed leader in enzyme research & complex enzyme eco-friendly solutions

 Chandrakant Laxminarayan Rathi, founder, promoter of Advanced Enzyme Technologies Ltd ranked among the top 15 global companies in terms of enzyme sales having more than 700 customers spanning presence across 50 countries worldwide, has been voted by the pharma leaders board as Biotech Leader of the decade at the 9th Annual pharmaceutical Leadership Summit & Pharma Leaders Business Leadership Awards 2016 in Mumbai on 23rd December 2016 organised by Pharma Leaders, india’s oldest & Asia’s most analytical news media in healthcare communications.

Announcing the name of Chandrakant Laxminarayan Rathi, Satya Brahma, Chairman of Pharma Leaders Group stated that, “the rise of Advanced Enzyme as a global leader is primarily driven by Chandrakant Rathi’s visionary leadership & deep understanding of the enzyme market both in india & abroad & offering customized eco-friendly enzyme solutions. With close to nearly four decades in the market, Rathi has been phenomenally successful since 1989. Rathi has demonstrated exceptional entrepreneurial skill as a strong & aggressive biotech leader propelling the company to a successful listed company in 2016  which recently enjoyed a spectacular IPO, further consolidated the market by acquiring  70 per cent stake in JC Biotech, an active pharmaceutical ingredients manufacturer”. The company will now have an added advantage of a dominant leadership in API Serratiopeptidase, which is an anti-inflammatory enzyme, will make company a competitive edge along with flexibility in production.

clrathi

The coveted & prestigious title “Biotech Leader of the Decade “would be conferred to Chandrakant Rathi in a power packed presence of more than 350 healthcare leaders at Pharma Leaders 2016 annual award ceremony. The event will also felicitate 30 top pharma healthcare companies & industry leaders in a glittering award ceremony. Chandrakant Laxminarayan Rathi, Promoter and Managing Director, Advanced Enzyme Technologies holds a Bachelor‘s degree in Science (Chemical Engineering) from National Institute of Technology, Rourkela. He has over 37 years of experience in the enzyme industry and was one of the co-founders of Rathi Papains Private Limited incorporated in the year 1978, which was engaged in the business of manufacturing of enzymes from papain. In the year 1986, he joined Messrs Super Organic Research Laboratories as a partner till the year 1987 (which came to be acquired by the Company at a later stage). Subsequently, he promoted and incorporated the Company in the year 1989 and is currently responsible for the management of the entire operations of the Company and its Indian subsidiaries, including strategic initiatives of our businesses.

Myntra wins India’s Most Admired & Valuable Power Brand Award 2016 at 7th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2016

Myntra’s Double Bonanza, ILC Power Brand Awards & Over 7000 Orders in a minute& over 3 million products  with The fourth edition of Myntra’s End of Reason Sale (EORS)

Myntra received India’s Most Admired & Valuable Power Brand Award 2016 at 7th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2016

The leading e-commerce major “Myntra” achieved Milestones & Accolades in the first week of july where Myntra was declared winner in the top branding award category surpassing all leading e-commerce brands in a nation-wide competition that kept the nation voting for sixty days. Network 7 media Group, asia’s most analytical news media in mainstream segments announced the coveted recognition at a power packed gatherings which included who’s & who’s of india’s business establishments, fashion, jewellery,politics, social entrepreneurship, medicine & infrastructure. Over 350 influential leaders of the country congregated in mumbai on 1st July at the historic 7th annual award ceremony.Ms. Gunjan Soni, CMO & Head of International Brands, Myntra received the award in a glittering award night.Dr.Lalit S. Kanodia, the founder and Chairman of Datamatics Group of Companies & Mrs. Sandra Rajnikant Shroff of United Phosphorus Limited were the Chief Guest of the Program & felicitated the awards to Myntra. Myntra surprised the stage with a Delivery boy present with Gunjan to receive the award.

Accepting the recognition, Gunjan Soni said ” The award reflects the commitment of the entire family of Myntra to be a leader in the online space with cutting edge technology & be the trend-setter. We at Mantra do understand the aspirations of the growing customers & each day we experiment new strategies to meet the customer satisfaction, delivery deadlines, original & quality products significance & thrust. This award is the reflection of our continued service as a reliable partner of Indian masses”. Satya Brahma, Chairman & Editor-In-Chief of Network 7 Media Group said ” The rise of Myntra as a power Brand in indian online space will continue in coming years as the process technologies, recruitment staff selection, training, quality checking & periodic check of customer feedbacks are world-class & the award signifies Myntra’s growth as a Brand Leader in the indian online space”.

myntra 1 myntra 2jpg myntra sandeep

The Success at The fourth edition of Myntra’s End of Reason Sale (EORS)

The fashion e-tailer exceeded its target of achieving 20x the daily sales target, with actual performance at 23x.The two-day (July 2 and 3), heavily discounted sales format offering discounts ranging 30-80 per cent was an attempt by the e-tailer to attract offline shoppers who wait for End of Season sales which typically stretch 6-8 weeks. Myntra concluded the sales with over 3 million products ordered by discount-happy shoppers, attracting an unprecedented 37 million visits and a high 30-per cent share of first-time buyers. The company claims to have processed about 7,000 orders per minute at peak during the two-day sale.

Myntra is India’s leading e-commerce platform for fashion and lifestyle products. A one-stop destination for trendy apparel, footwear and accessories, the company has partnered with over 2000 leading brands to offer shoppers from the latest in fashion and lifestyle wear. Myntra’s mobile platform transforms the way customers shop for fashion online, by capturing user’s lifestyle & context in a unique manner and making it more personalized and social.  It connects fashion lovers with their favorite brands, celebrities and influencers of similar taste and engages them with the latest in fashion content, new trends and collections. In addition to popularising trends in the urban market, the brand has also witnessed an enthusiastic reception from Tier II and III cities who have limited access to fashionable brands and account for around 60% of its business. With the mission to help people look good, Myntra works on constantly expanding its reach and improvising its offerings to cater to the needs of Indian shoppers. Few of its offerings include the most extensive in-season product catalogue, 100% authentic products, Cash on Delivery and a 30 day Exchange / Return policy, making Myntra the most preferred shopping destination in the country.

Myntra has been constantly working towards enhancing customers shopping experience at every level of contact. Here are few initiatives and developments that took place in the last 12 months which has impeccably enhanced the customer experience, making Myntra a popular destination to shop online.

Effective Technology Application to enable ‘Social & personalized shopping’

Myntra has been on the forefront of technology application and innovation and continues to invest heavily in this aspect. To build a personalised shopping mobile experience, Myntra launched features such as ‘Style Forum’, ‘Profiles’, ‘Shots’, ‘Fashion Feed’ among others.

 ‘Style Forum’ brings shoppers closer to the real world experience of asking for the opinion of their friends or help from style experts. ‘Fashion Feed ‘ on the landing page provides users fresh content every time they open the app and also allows them to follow conversations of particular interests or follow friends for regular updates. ‘Profiles’ allow brands and fashion influencers to create their own presence and showcase collections. Another feature, ‘Shots’ allows shoppers to share their style statements by posting pictures of outfits, selfies, shoes, accessories, makeup & more from their phone gallery or camera and also tag Myntra products to it.

All technology products and applications have been built in house by a team of qualified engineers.

Deep Relationships with brands to bring best shopping experience at great price

Myntra has been steadily growing its base with more and more national and international brands partnering to offer their products. The company currently commands of over 2000 brands and 2,30,000 styles to offer its customers. Myntra has also strengthened its international brand segment, allowing consumers to experience the latest in fashion globally, in India by offering over 25 reputed international brands, with most of them being exclusively retailed at Myntra.The ‘Myntra Annual Brand Meet’ held last year hosted over 800 brands to discuss how technology will build and transform the future of fashion. Every year this platform helps Myntra & its brand partners address the changing customer needs, supply chain highways & new innovations in technology in order to create new shopping experiences for customers.

Winning Culture

Myntra has a winning non-hierarchical culture that encourages ideas and innovations to flow smoothly within the organisation.

The company continues to roll out benefits & progressive HR initiatives aimed at making the company a great workplace for employees, especially during important life events. For instance a six month paid maternity and paternity leave besides providing an Adoption Assistance. Platforms such as hack nights and coffee corner sessions encourage employees to ideate and share out of the box ideas to grow the business and enhance customer experience.

Myntra has built one of the most fashionable offices in India. The two buildings have been designed as an ode to the World of Fashion to inspire creativity among employees.

Recognized as a Power Brand for its customer centric approach

Myntra is today recognized as a customer obsessed power brand among its consumers, with the brand recall at 90%. This can be attributed to a superior customer experience on the back of most progressive and innovative marketing campaigns. Over the last year, various campaigns such as Roadster’s ‘The Road is Waiting’ & ‘Pocketman’ which revolves around outdoor companion for the young have won many awards including Bronze at Effies. Even Anouk’s ‘Bold is Beautiful’ series which presented the four facets of choices in the lives of the modern Indian women was awarded ‘E-Commerce Disruptor of the Year’ by Bloomberg TV, ‘The Abby’s’ in Gender sensitive category, among others.

 Last year, Myntra launched a fashion brand ‘Moda Rapido’ powered by artificial intelligence. The brand helps consumers discover products according to the fashion trends and their particular tastes in style. To overcome sizing solutions, the company launched Shape ID guide ‘Shop by Shape’ solution through which customers are sure to find the best apparel to suit their body type along with the comfort of a Myntra style advisor offering suggestions based on their Shape ID. Myntra is aggressively focused on enhancing customer experience and achieved a 95% score for perfect order fulfillment which meant orders delivered on time to the right place, with the right product in the right condition on time. The company also received a 90% score for unaided recall of brand.


India Leadership Conclave 2016 Jury posed the questions to team Myntra & here are the answers.

The Question :

Describe the career highlights & top moments?

The Answer : 

Myntra has witnessed a series of revolutionary events and achievements since its birth in 2007 as an online B2B product personalization platform. Later in 2008 – 2011, Myntra received series A,B, & C funding from IDG, Tiger and Accel Partners. In 2011, Myntra established its logistics arm, achieved over 1Mn registered users and crossed launch of over 150 brands and became the largest online retailer of fashion & lifestyle products in India in 2012. Starting 2012, Myntra launched in-house brands Roadster, Dressberry, Kook n Keech, HRX and others. In 2013, Myntra became the first eCommerce Platform to Launch ‘Product Exchange’ which till today has provided great convenience to consumers. In early 2014, Myntra raised funds from PremjiInvest and by May, Myntra and Flipkart merged to form 50% of market share in online fashion and both Myntra & Flipkart continue to operate independently.

In 2015, Myntra transitioned to mobile only platform and by mid-July, the company appointed Ananth Narayanan as its CEO. In late 2015, Myntra launched few more in-house brands including ‘All About You’ by Deepika Padukone. Through all these years, Myntra has been growing tremendously and is currently doubling in revenues each year and on course to become a billion dollar company by 2017.The company also had few top level executives such as Ananth Narayanan (CEO), Gunjan Soni (CMO & Head of Intl’ Brands), Ambarish Kenghe (Head of Product), Ananya Tripathi (Head of Strategy & Planning) join during last year.

The Question :

What are the unique differentiators of this Nomination that would merit this category to be considered for an award?

The Answer : 

Myntra has been focused on building a brand that clearly differentiates it from the rest. As mentioned above, the brand’s key differentiator is being the largest and leading fashion etailer in India, offering consumers a curated collection of over 2.3L products from the best of fashionable brands.

A customer centric company, Myntra is focused on enhancing its online shopping experience at every touch point. The company’s NPS score stands as a testimony to the brand’s loyal customer relationships. Also brand’s impeccable quality of service, customer care teams and friendly exchange and returns policy makes it a popular destination for shoppers to shop online.

Another key differentiator is Myntra’s innovative and disruptive technology. As fashion is a very personal experience, Myntra constantly works towards transforming fashion shopping into a social and personalized experience and connecting fashion lovers with influencers, brands, celebrities and people of similar taste. The company has been at the forefront of technology application and innovation and will continue to invest heavily in this aspect.

Last but not least, Myntra’s winning culture has been the driving force behind company’s phenomenal growth & success. A company’s culture can have a powerful impact on its performance. Myntra’s culture provides employees opportunities to experiment and innovate, world-class infrastructure and engagement initiatives, work-life balance – creating one of the best workplaces for work & fun. It’s the company’s culture that binds employees together and it’s the hardest thing for others to copy.

The Question :

What is your Vision & where you want to see yourself in the year 2016?

The Answer : 

Myntra’s vision is to be the largest fashion & lifestyle destination, helping 50 million Indians ‘Look Good’ by 2020. The company aims to achieve its vision by offering customers with best of fashion & lifestyle from Indian and International brands, the best-in-industry customer service and build a community for consumers to engage on daily fashion choices and moments.

In the year 2016-2017, Myntra will achieve the following aspirations

  • 20 mn engaged users on the Myntra platform
  • Highest Net Promoter Score (NPS) in the industry. NPS is an index that measures customer’s overall satisfaction with a company’s product/service and customer’s loyalty to the brand.
  • Highest Top of Mind recall with the consumer in online fashion segment
  • GMV(Gross Merchandise Value) run rate of USD 1 bn and on track to be profitable in next 18 months

 

Nagpur based Infrastructure giant SMS Infrastructure’s Anand Sancheti to receive the prestigious Transformational Business Leader of the Year 2016

Nagpur based Infrastructure giant SMS Infrastructure’s Anand Sancheti to receive the prestigious Transformational Business Leader of the Year 2016

India Leadership Conclave & Indian Affairs Business Leadership Awards 2016 declared Mr. Anand Sancheti, MD, SMS Limited in  the very prestigious category of Transformational Business Leader of the Year 2016 at the ILC Power Brand Awards 2016 to be held in mumbai on 1st july 2016.Mr Anand Sancheti was declared winner after the jury looked into the landmark achievements that he led to ensure SMS Group as one of the top company.

Over the years, some exceptional business leaders have been nominated by their peers – the leaders in the marketplace and workplace who have made their mark, inspiring and empowering those around them to develop their potential and reach their goals.India Leadership Conclave popularly known as “ILC Power Brands” are Asia’s most prestigious & credible  recognition for those that have excelled in their respective industry. With more than 15 years of experience in conducing & executing world-class awards programs with the use of state of art technologies & research  has indeed gone from strength to strength distinguishing best in class organizations. The set of prestigious & coveted awards are from asia’s most definitive & credible news media in mainstream journalism  is from the organisers of  Network 7 Media Group, the flagship media company of Indian Affairs’s Annual Event, asia’s most analytical news media is now celebrating its 7th successful & glorious years of achievement. Built upon a stringent methodology that is combined with a rigorous approach in selecting the best institutions operating within asia, the awards are adjudicated by an eminent panel of jury members who collectively have several decades’ worth of evaluating industry awards in asia using the powerful research public voting mechanism. Those who also made it to the top list included people from cinema, corporate, philanthropy etc. Actor of the Decade ( Male)- Govinda, Actress of the Decade ( Female)- Karishma Kapoor, Film Maker of The Decade – Sanjay Leela Bhansali, Social Enterprise of the Year 2016 – Fulora Foundation, Emerging Talent & Debut Actress of Indian Cinema 2016 – Tina Ahuja, Indian Affairs India’s Most Promising Yoga & Nutritionist Expert 2016 – Eefa Sharof, Indian Affairs millennium business leader in homeopathy medicine 2016 – Dr. Mukesh Batra, Chairman, Dr. Batras, Peace Leader of the year 2016 – Dr. Huzaifa Khorakiwala, CEO, Wockhardt Foundation & Executive Director, Wockhardt Ltd

ilc winners low

Factfile

A Commerce Graduate with diploma in finance. He is looking after the management of the Company. Heads the finance division of group. Was involved in Project implementation for a period of more than 7 years. He was also involved in the successful implementation of first PPP project in Roads Sector, in India. Has closely worked in Professional Capacity with McKinsey SBI capital Market Ltd and National Highway Authority of India. He has been a faculty for structured Finance and Project finance at World Bank Knowledge Forum, State Bank of India, etc. He also holds various Management Positions within and outside Group Companies.

infra

SMS Limited

Sustainable growth, Multi-sectoral presence, Quality, Innovation, Technical expertise, Strong financials and a socially responsible company since 1963, SMS Limited is Central India’s largest Infrastructure Group. Company has Pan India presence with Corporate Office located at Nagpur. Employee base of more than 1800 with attrition of less than 2%, satisfaction of all clients and continued track record of timely completion with quality are the key attributable for the success of the company.

Roads: In Roads, Highways, Bridges and Airports the company has executed number of prestigious works. Country’s first BOT project in Road was successfully executed in 1997 at a period when Power, Shipping, Telecommunication privatization had failed. The success of Durg-By-Pass is still the largest mentioned success story by the erstwhile Governments. Country’s fifth highest density corridor was completed by the company in year 2004. Longest Twin-Tube tunnel in Sahyadri region with country’s second highest viaduct was also completed by the company. The company has also completed various Road projects in Naxal infected areas contributing to the development of the region. Several Awards by Geotechnical Society, Builders Association of India, Concrete Society, Institute of Engineers, etc have been bestowed upon the company for its excellent performance.

Toll Management: Company has contributed significantly in establishing the user’s fee and people’s readiness to pay toll during the initial stages. At several platforms the company has shared its knowledge and helped in motivating people to pay for better quality roads. Company has operated and managed long stretches of roads in all parts of the Country. The Vidyasagar Setu toll collection provided an increase of 230% in revenue to West Bengal Government. Limca Book of records has recognized the efforts of SMS Limited for Highest ever Toll Collection reported. National Highway Authority of India has awarded Best Operation & Maintenance Contractor to SMS for a continuous period of two years.

Railway: With continued efforts to its contribution to the transportation sector the company has emerged as one of the largest Railway Contractor. Company has capability and has demonstrated its expertise at various occasions in complex Railway Projects. Railway tunnel in Himalayan terrain, Sahyadri region, Railway embankment protection works on the banks of Brahmaputra river, new railway line in thick naxal belt of mineral rich Chhattisgarh State and private railway embankments for Khaparkheda, Chandrapur, Sarni, Koradi Thermal Power Stations are the few landmark projects executed by the company. The company not only does the Civil work but is also actively involved in permanent way linking of Railway tracks, signaling and telecommunications, station buildings etc. The company has a motto that “You give us the land and we will provide you complete Railway line in sync with Indian Railways”.

Urban Development: In its continued foray in transportation sector, Company has constructed Asia’s largest underground Car Parking facility at Kamlanagar, Delhi. This engineering marvel has 9 floors of underground car park with capacity of more than 800 cars. Mumbai’s largest radio fleet taxi – TabCab is promoted by the Company and is successfully running despite the disruptive app-based aggregators flooding the market.

Irrigation: Water is the driving force of all Nature. The company having recognized its importance, SMS Limited is a leading Irrigation contractor having its works Pan India. We have successfully completed several dams, barrages, reservoirs and all types of water retaining structures. For transportation of water the company has executed kilometers of main canal, distribution canal, tunnel and pipeline. For low-lying areas company has executed lift irrigation schemes. For drinking water supply we have executed intake wells, pipelines and tap connections to hundreds of villages.

Water Reuse: Use of wastewater is the need in the era of depleting water table and dearth of water resources. Realizing this, the company has participated in India’s largest water reuse Sewage Treatment Plant with treated water to be used for Super Thermal Power Station through a 19-kilometer pipeline. Turnkey construction with Operation and Maintenance of 10 years is being carried out by the company. Company has equity stake in several Common Effluent Treatment Plants.

Waste Management: Waste management is a service to the Nation and its humble contribution to Nation. Company is managing Bio-Medical Waste Treatment plants at Delhi, Lucknow, Raipur, Ranchi, Aurangabad, Nasik, Kampala (Uganda) and Mumbai (Asia’s Largest). Extension to BMW, Company also has the rights for transportation and management of Common Hazardous Waste Treatment and Scientific Disposal Facility at Pune and Butibori. Pune plant is a state-of-the-art project having visited by several companies from across the Globe. Company has bagged the project at Goa, Aurangabad and Bangalore for similar works. Several Awards have been bagged by the Company for its efficient waste management facilities.

Mining: In its contribution to the progress of the Nation, Company is Mine Development and Operation (MDO) for World’s largest underground Uranium mine. The Greenfield project with complete mechanization is being executed by us. The world-class technology with skill development with local has been a subject for several research papers in the field. The Company owns largest number of plant and machinery used for underground coal extraction. Company contributes more than One Million Ton of underground coal in its endeavor to save environment from opencast mines.

Electrical: To provide electricity in the farther corners of this Country in the state of Bihar, Jharkhand, Chattisgarh, Tamilnadu, Rajasthan, Maharashtra etc. we are continuously striving. In last 5 years Company has provided connections to more than 3.5 lac households of Below Poverty Line. The infrastructure development like substations, lines, loops, switching stations, meters, etc. for continuous supply is undertaken by the Company in a large manner. Company has installed more than 18000 distribution transformers during last 5 years.

The robust financials have always complemented to the growth of the Company. Present Net-Worth of the Group is more than INR 450 Crore with enviable performance ratios. The external credit rating agencies have placed the Company in the ‘A-’ Category for its balanced financial management and well chalked out growth momentum.

On the CSR front Company has contributed largely in the development of a Cancer Hospital. Company is actively engaged in providing school uniforms and kit to thousands of children through ‘CAFE’ and Hostel and education facilities for AIDS infected children left by their parents through ‘CARE’.Over last several years, the sole motto of SMS Ltd has been nation building. A strong nation rests on its robust infrastructure. With this vision, SMS Ltd started its business 52 years ago and today has become a giant in this filed. Our step by step progress in diversified segments have made us reach at a consolidated turnover of Rs. 1750 crore.

Innovation in engineering had been the driving force for the company and hence, the company had taken calculated risks in bidding for niche projects in various segments. We have never backed out of our projects even when faced with difficulties and have gone ahead with completing them.

At different times, we had brought globally renowned technologies to India by entering into consortium with foreign experts like Westinghouse Corporation, Proviron Technology BV, etc. to take our infrastructure to next level.

Describe the career highlights and top moments:

  • 1997- Awarded first BOT Project of National Highways Authority of India
  • 2007- Awarded mining contract for Asia’s largest Uranium Mine
  • 2008- Commissioned India’s largest Plasma Gasification Plant converting waste to energy
  • 2009 – Started Asia’s biggest Bio Medical waste facility in Mumbai
  • 2011- Launched Tab Cab, India’s largest fleet of radio cabs
  • 2012 – First introduction to India of low cost continues mining through blast free technology
  • 2013- Commissioned India’s first fully automated underground car parking system with 828 car park spaces in Kamla Nagar, Delhi
  • 2014- Became India’s second largest waste processor in terms of volume.
  • 2015- Featured in the Fortune India magazine July 2015 issue.
  • Consistent Growth
  • Strong Order Book
  • Most Diversified portfolio
  • Multisectoral Presence
  • Only company to feature in Fortune India Magazine
  • Presence in sunrise sectors like underground Mining, Sewage Treatment, Electrical and Waste Management.

What is your vision and where you want to see yourself in the year 2020?

Infrastructure is the basic requirement for any nation to grow. By 2020, the country would have moved to a much advanced technology with optimization of resources. In next four year, the nation would be moving towards faster and economic transportation system, generating energy from untapped resources, aiming hygienic and cleaner facilities. Tolling would have shifted entirely on e-tolling. Bullet train in India is now a reality with Gatimaan express being launched. Many more bullet trains will be launched and we, already being in this segment, will be actively participating in it.

As resources are getting dearer, underground mining is scaling greater depths. Also, open cast mining would be a history due to issues relating to land acquisition and environmental clearances. We, being the only few underground miners in India are already poised for a big growth. We will not only be mining minerals, but will also be going for its beneficiation so as to give maximum yield.

As energy resources are getting dearer, the country will be moving more towards clean and renewable energy. We are already generating energy from waste. With pollution norms becoming more stringent, more projects for treatment of waste and generating energy from it will be coming.

With increase in on road vehicles, every big city is facing problems related to parking. Our state of art underground parking facility is the simplest option for this. Going ahead, every city will need multiple parking facilities and we will be surging ahead in this segment. Also, radio cabs, which earlier restricted only to metros, has now forayed in tier II cities. There is a great scope in providing luxurious and affordable public transport system to all.

In urban development, the company has already started its first multi specialty state of art hospital and research centre in Nagpur. This medical facility will be larges in central India and will come up with not only treatment of patients, but also providing world class rehabilitation facilities to old age persons.

We also intend to provide housing to persons of Low Income Group and affordable cost and will be coming up with such facility. We have a humble presence in hospitality sector with three restaurants. We plan to have our chain of restaurants across India giving a unique taste of Indian and continental dishes with our expertise to create fusion of the two.

We are confident that as infrastructure will grow, requirement of Roadside facilities will grow. We target at setting up safety rest areas, parking and toilet facilities alongside highways. This will be coupled with repair facilities for vehicles, basic medical and first aid and internet kiosk with Public Sahayta Kendra. Public Sahayta Kendra will cater to the commuters as well as the nearby villages.

Education is right of every child and we are already committed to it. The company is running two schools MHK Sancheti Public School and Dharampeth Kanya Shala. CAFÉ stands for Child Adoption for Education and CARE stands for Child Adoption for Rehabilitation and Education. The two NGOs are entirely adopted by SMS Ltd. Going ahead; we intend to bring in more schools under our net.

By 2020, SMS would be a public listed company achieving a CAGR of more than 10% on a yoy basis. SMS would be the leader in underground mining and waste management and would be working in overseas locations also.

Today, when the global economic scenario looks gloomy, India is the only hope for the entire world. Our economy has remained unaffected by the global slowdown. Besides, as the major population is young and working, the productivity of the country will always be marching northwards.  Our Prime Minister, Shri Narendra Modiji had also quoted several times that the development infrastructure is the basic requirement to take our country to the next level.

Aligning ourselves with this vision, we intend to create best infrastructures for the nation. We intend to touch every Indian and make a positive difference in their lives, maybe on our toll booths, maybe in our taxi or maybe in our hospital or our any other project.

The Background

Infrastructure sector is a key driver for the Indian economy. The sector is highly responsible for propelling India’s overall development and enjoys intense focus from Government for initiating policies that would ensure time-bound creation of world class infrastructure in the country.

Infrastructure sector includes power, bridges, dams, roads and urban infrastructure development.

Market Size

India needs Rs 31 trillion (US$ 454.83 billion) to be spent on infrastructure development over the next five years, with 70 per cent of funds needed for power, roads and urban infrastructure segments.

The Indian power sector itself has an investment potential of US$ 250 billion in the next 4-5 years, providing immense opportunities in power generation, distribution, transmission and equipment, according to Mr Piyush Goyal, Union minister of coal, power and renewable energy.

The Indian construction equipment industry is reviving after a gap of four years and is expected to grow to US$ 5 billion by FY2019-20 from current size of US$ 2.8 billion, according to a report@ released by the Indian Construction Equipment Manufacturers’ Association (Icema).

Foreign Direct Investment (FDI) received in construction development sector from April 2000 to December 2015 stood at US$ 24.18 billion, according to the Department of Industrial Policy and Promotion (DIPP).

Investments

India is witnessing significant interest from international investors in the infrastructure space. Many Spanish companies are keen on collaborating with India on infrastructure, high speed trains, renewable energy and developing smart cities

  • Airports Authority of India (AAI) plans to develop city-side infrastructure at 13 regional airports across India, with help from private players for building of hotels, carparks and other facilities, and thereby boost its non-aeronautical revenues.
  • The Asian Development Bank (ADB) and Government of India signed a loan agreement of US$ 80 million, which is the third tranche of a US$ 200 million financing facility under the North Eastern Region Capital Cities Development Investment Programme, and will be invested for improving water supply, solid waste management and sanitation in the cities of Agartala and Aizwal, the capital cities of Tripura and Mizoram respectively.
  • Maharashtra State Government plans to launch infrastructure projects worth Rs 73,367 crore (US$ 10.78 billion) in Mumbai and neighbouring areas in 2016, which include coastal road, Trans harbour link, metro rail, airport and road projects.
  • The Government of India has earmarked Rs 50,000 crore (US$ 7.34 billion) to develop 100 smart cities across the country. The Government released its list of 98 cities for the smart cities project in August 2015.
  • BNP Paribas Lease Group, subsidiary of BNP Paribas Group, has acquired 5 per cent stake in Srei Infrastructure Finance, by selling its entire 50 per cent stake in Srei Equipment Finance Limited (SEFL) to Srei Infrastructure Finance, thus allowing them to play a larger role in the infrastructure finance business.
  • Private equity giant Carlyle Group is planning to invest Rs 500 crore (US$ 73.36 million) in Feedback Infra, which could make the US firm a major shareholder in the Gurgaon-based infrastructure services company.
  • In the month of November 2015, among various areas of infrastructure spending by the government, the roads segment led in terms of tenders issued (59 per cent of total tenders) and contracts awarded, with an increasing shift to Engineering, Procurement and Construction (EPC) type of contracts#.
  • PTC India Financial Services (PFS) and India Infrastructure Finance Company Limited (IIFCL) have signed a Memorandum of Understanding (MoU) to jointly provide funding for infrastructure projects in India, particularly in the energy sector.
  • France has announced a commitment of € 2 billion (US$ 2.17 billion) to convert Chandigarh, Nagpur and Puducherry into smart cities.
  • The Construction Industry Development Board (CIDB) of Malaysia has proposed to invest US$ 30 billion in urban development and housing projects in India, such as a mini-smart city adjacent to New Delhi Railway Station, a green city project at Garhmukhteshwar in Uttar Pradesh and the Gangacleaning projects.
  • The Government of India has unveiled plans to invest US$ 137 billion in its rail network over the next five years, heralding Prime Minister Narendra Modi’s aggressive approach to building infrastructure needed to unlock faster economic growth.
  • The Government of India has announced highway projects worth US$ 93 billion, which include government flagship National Highways Building Project (NHDP) with total investment of US$ 45 billion over next three years.

Government Initiatives

The Government of India is taking every possible initiative to boost the infrastructure sector. Some of the steps taken in the recent past are being discussed hereafter.

  • The Government of Japan, through Japan International Cooperation Agency (JICA), has committed to provide a soft loan of JPY 19.064 billion (US$ 161.2 million) to Government of India at an interest rate of 0.3 per cent per annum for the project of pollution abatement of Mula-Mutha river in Pune, Maharashtra under the National River Conservation Plan.
  • Government of India plans to use the new hybrid-annuity model for allocating contracts under the Public Private Partnership (PPP) projects in highways, Namami Gange and Railway Projects, which will help overcome the challenges faced by private developers in the Build-Operate-Transfer (BOT) Toll and BOT-Annuity models.
  • Budgetary allocation for Roads and Railways in the Union Budget 2016 has been increased to Rs 218,000 crore (US$ 31.98 billion) with an aim to boost the private investment cycle.
  • The Ministry of Road Transport and Highways plans to build five more greenfield expressways across the country, which are expected to reduce travel time and propel economic growth.
  • The Union Ministry of Urban Development has approved an investment of Rs 495 crore (US$ 72 million) under the Atal Mission for Rejuvenation and Urban Transformation (AMRUT) for FY 2015-16 which will be used for water supply, sewerage networks and septage management, storm water drains, urban transport and provision of green spaces in 13 cities spread over six states.
  • Prime Minister of India Mr Narendra Modi indicated that the government has rolled out stuck projects worth Rs 4 lakh crore (US$ 58.69 billion) in the past six months (ending November 2015), while stating that infrastructure development is the government’s top priority in order to improve economic growth.
  • The Union Cabinet has approved several reforms such as allowing National Highways Authority of India (NHAI) to extend the concession period for current incomplete projects in build-operate-transfer (BOT) mode.
  • Government of India plans to launch the National Infrastructure Investment Fund (NIFF) with an initial corpus of at least Rs 40,000 crore (US$ 5.87 billion).
  • The Ministry of Urban Development has approved an investment of Rs 19,170 crore (US$ 2.81 billion) for improving basic urban infrastructure in 474 cities in 18 states and Union Territories (UTs) under Atal Mission for Urban Rejuvenation and Transformation (AMRUT) for 2015-16.
  • Department of Industrial Policy and Promotion (DIPP) has set up an online monitoring system for on-going projects under the Industrial Infrastructure Upgradation Scheme (IIUS).
  • The Ministry of Urban Development has decided to allow the use of construction & demolition waste up to 20 per cent in construction of load bearing items and up to 100 per cent for non-load bearing purposes. This provision is expected to significantly help in reuse of such waste, in line with ongoing efforts under Swachh Bharat Mission (SBM).
  • The central government has approved amendments to ‘The National Waterways Bill, 2015’ which will provide for enacting a central legislation to declare 106 additional inland waterways, as the national waterways.
  • The Government of India plans to award 100 highway projects under the public-private partnership (PPP) mode in 2016, with expectations that recent amendments in regulations would revive investor sentiments in PPP projects in the infrastructure sector.
  • The Reserve Bank of India (RBI) has notified 100 per cent foreign direct investment (FDI) under automatic route in the construction development sector. The new limit came into effect in December 2014.
  • The Government of India has relaxed rules for FDI in the construction sector by reducing minimum built-up area as well as capital requirement. It has also liberalised the exit norms. In fact, the Cabinet has also approved the proposal to amend the FDI policy.
  • In the Budget 2015-16, the capital outlays for roads, and railways have been increased by Rs 140.3 billion (US$ 2.05 billion) and Rs 100.5 billion (US$ 1.47 billion) respectively.

Road Ahead

Indian port sector is poised to mark great progress in the years to come. It is forecasted that by the end of 2017 port traffic will amount to 943.06 MT for India’s major ports and 815.20 MT for its minor ports.

Along with that, Indian aviation market is expected to become the third largest across the globe by 2020, according to industry estimates. The sector is projected to handle 336 million domestic and 85 million international passengers with projected investment to the tune of US$ 120 billion. Indian Aviation Industry, which currently accounts for 1.5 per cent of the gross domestic product (GDP), has been instrumental in the overall economic development of the country. Given the huge gap between potential and current air travel penetration in India, the prospects and possibilities of growth of Indian aviation market are enormous.

Exchange Rate Used: INR 1 = US$ 0.0147 as on March 01, 2016

Govinda, Sanjay Leela Bhansali,Karishma Kapoor, Dr. Mukesh Batra,Dr.Huzaifa Khorakiwala,Tina Ahuja, Eefa Shrof, Fulora Foundation among others selected for ILC Power Brand Awards 2016

Govinda, Sanjay Leela Bhansali,Karishma Kapoor, Dr. Mukesh Batra,Dr.Huzaifa Khorakiwala,Tina Ahuja, Eefa Shrof, Fulora Foundation among others selected for ILC Power Brand Awards 2016. Indian Affairs announces the winners in Jury Category at the 7th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2016.

India Leadership Conclave & Indian Affairs Business Leadership Awards also known as ILC Power Brands today declared top names from cinema,medicine,yoga,social sector at the asia’s most awaited annual edition currently in its 7th year in the non-voting jury category. These  prestigious awards at Indian Affairs awards hasl been reviewed  by an eminent panel of top Professionals & World Renowned Academia followed by an extensive selection methodology via public voting through Network 7 Research, the research wing of Network 7 Media Group to recognize the outstanding contribution in the field of  medicine, Cinema, Social Enterprise, exemplary yoga practice, and aptitude for & interest in bringing a change in the system through their own respective domains. India Leadership Conclave 2016 which is also hosting the historic Conclave titled Advantage India – It is now or never will be held in mumbai at Hotel Hilton Mumbai International Airport,on friday,1st July 2016. The set of prestigious awards wil be conferred on a glittering award night.

ilc winners low

Announcing the names of the winners, Satya Brahma, the founder of India Leadership Conclave Mr. Satya Brahma said At India Leadership Conclave’s dialogue & award forum, “our attempt & objective is to discuss the complex issues in minute details & yes we have been phenomenally successful not only because we have been able to again raise the bar for our industry peers in terms of top-notch participation & execution for which ILC Power Brands are known for, but also because we have been able to create outstanding content, debates & first opinions for our participants. These winners reflect our deep commitment to promote innovations & creativity & are meant to motivate & encourage to create more landmarks in near future”.

Indian Affairs Power Brand Awards at the India Leadership Conclave’s Annual Editions are Network 7 Media Group’s most prestigious & coveted  set of awards for successful achievers in business, social enterprises. Since its inception, the award categories have gained momentum because of its transparent process of selection & stringent methodology powered by Network 7 Media Group’s eminent panel of jury members.. Over the last six editions, needless to add, these awards have grown in prestige and stature. It has become the premier event of its kind in the country and a notable part of the Country’s business calendar. This valuable award has national, regional and global recognition and is awarded in the Corporate and Entrepreneurial categories.

Over the years, some exceptional business leaders have been nominated by their peers – the leaders in the marketplace and workplace who have made their mark, inspiring and empowering those around them to develop their potential and reach their goals.India Leadership Conclave popularly known as “ILC Power Brands” are Asia’s most prestigious & credible  recognition for those that have excelled in their respective industry. With more than 15 years of experience in conducing & executing world-class awards programs with the use of state of art technologies & research  has indeed gone from strength to strength distinguishing best in class organizations. The set of prestigious & coveted awards are from asia’s most definitive & credible news media in mainstream journalism  is from the organisers of  Network 7 Media Group, the flagship media company of Indian Affairs’s Annual Event, asia’s most analytical news media is now celebrating its 7th successful & glorious years of achievement. Built upon a stringent methodology that is combined with a rigorous approach in selecting the best institutions operating within asia, the awards are adjudicated by an eminent panel of jury members who collectively have several decades’ worth of evaluating industry awards in asia using the powerful research public voting mechanism.

Following are the list of Award Categories & Winners


 

  • Actor of the Decade ( Male)- Govinda
  • Actress of the Decade ( Female)- Karishma Kapoor
  • Film Maker of The Decade – Sanjay Leela Bhansali
  • Social Enterprise of the Year 2016 – Fulora Foundation
  • Emerging Talent & Debut Actress of Indian Cinema 2016 – Tina Ahuja
  • Indian Affairs India’s Most Promising Yoga & Nutritionist Expert 2016 – Eefa Shrof
  • Indian Affairs millennium business leader in homeopathy medicine 2016 – Dr. Mukesh Batra, Chairman, Dr. Batras
  • Peace Leader of the year 2016 – Dr. Huzaifa Khorakiwala, CEO, Wockhardt Foundation & Executive Director, Wockhardt Ltd

Indian Business Woman of the year 2016

Business Woman of the year 2016

1.Ms.Nadia Chauhan, JMD & CMO, Parle Agro Pvt. Ltd. (Code 07)
2.Ms.Lisa Srao, Chairman and MD, I Brands Beverages Ltd. (Code 08)
3.Ms.Ayesha Thapar, MD, Indian City Properties Ltd. (Code 09)
4.Ms.Aditi Kothari, Executive Vice President , DSP BlackRock. (Code 010)
5.Ms.Devita Saraf, Founder & Mentor, VU Technologies. (Code 11)
6.Ms.Priya Sachdev,Founder & CEO, Rock N Shop. (Code 12)

The Objective & Award Title Importance


The Businesswoman of the Year Award is Network 7 Media Group’s most prestigious & coveted  award for women achievers in business.  Since its inception, the award category has gained momentum becausde of its transparent process of selection & stringent methodology powered by Network 7 Media Group’s eminent panel of jury members.. Over the last six editions, the Businesswomen of the Year Award has grown in prestige and stature. It has become the premier event of its kind in the country and a notable part of the Country’s business calendar. This valuable award has national, regional and global recognition and is awarded in the Corporate and Entrepreneurial categories.

In the Awards’ 6 year history, the principles and objectives have remained consistent:

  • To create a mechanism for applauding and celebrating women’s contribution to the economy.
  • To recognise the success of women leaders in business, thereby creating a cadre of female role models whose achievements will inspire other women to raise their sights and reach their goals.
  • to be an iconic figure to the succeeding generations to emulate & influence..

Over the years, some exceptional business women have been nominated by their peers – women in the marketplace and workplace who have made their mark, inspiring and empowering those around them to develop their potential and reach their goals.


 

Cosmetic & Plastic Surgery will be the top of agenda amongst the rising consumers spendings, China’s cosmetic surgery industry is expected to double in value from 400 billion to 800 million yuan by 2019

This prestigious award Indian Affairs Indian of the Year 2016 – Cosmetic Plastic Surgery will be reviewed  by an eminent panel of Healthcare Professionals & World Renowned Academia followed by an extensive selection methodology via public voting through Network 7 Research, the research wing of Network 7 Media Group will recognize outstanding innovative medicine expert leadership, civic involvement, exemplary patient care, and innovative surgical procedures.

The listing & final ten finalists will move on to the next round of voting & six nominees will enter into contest to the coveted recognition. The selection of ten names are based on various factors. Seniority, Experience, Innovations, Milestone Achievements & remarkable exhibition of breakthrough research even in short career are some of the key features of the study. The decision of the Juries are final & binding.

The Shortlisted Six Finalists who made it to the top Six from a list of more than 435 consultants are

  1. Manoj Khanna, Cosmetic & Plastic Surgeon, Founder, Enhance AestheticClinics
  2. Viral Desai, Cosmetic & Plastic Surgeon,Founder, CPLSS
  3. Charu Sharma, Cosmetic & Plastic Surgeon ,Founder, Dr Charu Essential Aesthetic and Dermatology Clinic
  4. Harsh Bharat Amin, Cosmetic & Plastic Surgeon,Founder, ADORN Cosmetic Surgery
  5. Priti Shukla, Cosmetic & Plastic Surgeon , Founder, Dr. Priti Shukla’s AMBROSIA
  6. R. K. Mishra, Cosmetic & Plastic Surgeon, Founder, SIPS Super Specialty Hospital

 


 

About India Leadership Conclave & ILC Power Brand

India Leadership Conclave popularly known as “ILC Power Brands” are Asia’s most prestigious & credible  recognition for those that have excelled in their respective industry. With more than 15 years of experience in conducing & executing world-class awards programs with the use of state of art technologies & research  has indeed gone from strength to strength distinguishing best in class organizations. The set of prestigious & coveted awards are from asia’s most definitive & credible news media in mainstream journalism  is from the organisers of  Network 7 Media Group, the flagship media company of Indian Affairs’s Annual Event, asia’s most analytical news media is now celebrating its 7th successful & glorious years of achievement. Built upon a stringent methodology that is combined with a rigorous approach in selecting the best institutions operating within asia, the awards are adjudicated by an eminent panel of jury members who collectively have several decades’ worth of evaluating industry awards in asia using the powerful research public voting mechanism.

The Background 

 Indian Cosmetic & Plastic Surgery is estimated at US $ 200 Million Industry while China’s cosmetic surgery industry is expected to double in value from 400 billion to 800 million yuan by 2019

while buttock and breast augmentation remain the most talked about plastic surgeries, procedures such as facelifts, eyelid surgery, and ear and nose surgeries are among the most popular when it comes to maintaining a youthful appearance and reducing the effects of aging on the skin:

Whatever part of the world you live in, age, stress, sun damage, and other environmental factors contribute to a reduction in elasticity, deep creases, and blemishes on the face, BHP explains. When the skin loses its elasticity, it can create folds and fat deposits around the neck, as well as jowls around the jaw line; all of which can make a face look older than it actually is. A surgical facelift procedure can actually shed years from the facial skin by tightening up the muscles and skin in the face and neck. For those seeking a more temporary fix, Botox and facial fillers are also highly viable options.

Eyelid surgery, also known as blepharoplasty, is a plastic surgeon’s tool at eliminating those dreaded crow’s feet or sagging and bagging around the eyes. Just like the delicate tissue of the face, this skin around the eyes can lose its elasticity and further age the face, BHP notes. Fortunately, as the medical group explains, this surgical procedure can dramatically bring new life to the windows to the soul. Many people are surprised to learn that the ears and nose never stop growing, BHP notes. This is one of many reasons why many people seek out rhinoplasty procedures which can reshape or reduce these features and help breathe new life into one’s facial appearance, the medical group notes. What’s more, BHP notes, the surgery can be done in a remarkably subtle way, so that others might simply assume that the patient has enjoyed a long, relaxing holiday.It’s probably no surprise that the number of plastic surgeries and cosmetic procedures continue to increase in the United States as they become more affordable and less stigmatized. But new data suggest Americans going under the knife are increasingly conscious of their derrieres. Male patients are also becoming a bigger part of a market once dominated by women. According to the American Society of Plastic Surgeons (ASPS), there were 15.9 million surgical and minimally invasive cosmetic procedures performed in the United States in 2015, a 2% increase since 2014. The organization published its findings in a report, which analyzed statistics from 2000 to 2015 to track trends across the $12 billion industry.

Butt implants were the fastest growing type of cosmetic surgery in 2015, with Americans undergoing 2,540 of these procedures, a 36% uptick from 2014. The number of butt lifts performed also increased by 36% to 4,767 total procedures in 2015. Another facet of the business that’s changing is the patient base. Men are getting more plastic surgery and cosmetic procedures than ever, and for the first time, men accounted for more than 40% of the total 68,106 breast reduction surgeries performed in the United States, according to the report. That’s a 5% increase over the previous year and a 35% growth in the procedure among men since 2000.

The X Factor

As plastic surgery is becoming more common and accepted in men, we’re seeing more of them undergo procedures to tighten and tone problem areas, like the breasts,” “This procedure is often done in younger men who face genetic challenges with the size and shape of their breasts, and when appropriate, surgery can make a big difference in their lives.. It is not uncommon for young women to approach a plastic surgeon and ask to be transformed for things like deep double-eyelids and a V-line face

CHINA

China will become the world’s third largest cosmetic surgery market by 2019, with its market size estimated to double to 800 billion yuan from its current level due to people’s growing wealth, peer pressure deriving from social media platforms, and the influence of Korean pop culture, according to analysts. In 2014, China’s nascent cosmetic surgery industry was valued at 400 billion yuan, with more than 7 million people, most of whom are young women, having cosmetic surgery, according to the China Association of Plastics and Aesthetics (CAPA).

The industry group estimated China’s cosmetic surgery industry to double to 800 billion by 2019, making it the third largest market in the world. So What’s driving the demand in China’s cosmetic surgery market?

Apart from growing wealth, increasing peer pressure through “powerful” social media platforms — such as mobile messaging app WeChat and Twitter-like service provider Weibo — are also prompting people to pursue physical beauty harder than before, analysts from HSBC noted.

“Beauty and cosmetic surgery apps, which have millions of followers, encourage people to look at their own image with an ever more critical eye,” they said.

In addition, the “tremendous popularity” of Korean pop and lifestyle culture, known as Hallyu, is also changing the face of China’s younger generation.

In 2014, around 60,000 of Chinese people chose to visit Korea for cosmetic surgery, up 45 per cent from a year earlier, statistics from CAPA showed.

The big sellers in the industry are simple procedures that require no anaesthetic and “can be done during the office lunch break”, analysts said.

One of the most popular procedures is hyaluronic acid (HA) dermal filler, a simple non-surgical injection regarded as “safe and convenient” to help enhance facial contours, reduce wrinkles, hydrate and firm the skin.

China is a leading manufacturer of HA – which occurs naturally in the human body but diminishes as people age – and we expect HA dermal filler volume to increase more than 20 per cent annually over the next three years

The global plastic surgery market is categorized based on various surgical and non-surgical procedures. The surgical procedure segment is further sub-segmented into liposuction, nasal surgery, breast augmentation, eyelid surgery and tummy tucks surgeries. Non-surgery procedure includes photo rejuvenation and hair removal.

In terms of geographic, North America and Europe dominates the global plastic surgery market. This is due to rising aging population and high adoption rates of aesthetic products in these regions. The U.S. represents the largest market for plastic surgery followed by Canada in North America. In Europe, France, Germany, Italy, Spain and the U.K. holds major share of plastic surgery market. However, Asia is expected to show high growth rates in the next five years in global plastic surgery market due to increasing awareness about plastic surgery procedures and growing medical tourism industry. China and India are expected to be the fastest growing plastic surgery markets in Asia. In recent time, rising number of geriatric people along with growing demand for retaining young and beauty is key driver for the global plastic surgery market. In addition, technological advancement in surgeries and rising number of obese and over-weight people have also fueled the growth of global plastic surgery market. However, high cost of surgeries and stringent regulatory approvals are some of the major restraints for the global plastic surgery market. In addition, high risks of adverse effects associated with surgeries also obstruct the growth of global plastic surgery market. Increasing usage of plastic surgery biomaterials develops opportunity for the market. India is viewed as one of the most progressive countries for cosmetic surgical procedures and this trend is expected to continue in the near future. This is mainly due to the fact that cosmetic surgery has evolved beyond the traditional concept of being a ‘risky or ‘impractical procedure that was demanded by women who were overly conscious about their appearance. Today, people in India understand that cosmetic surgery is a highly specialized and advanced niche of plastic surgery that helps people attain happiness with fewer risks and greater affordability.

In the past, cosmetic surgeries in India were associated with celebrities and people of the affluent class. However, today, these surgeries are increasingly becoming popular and are being undertaken by the middle class. Increasingly, both men and women from the upper middle class group are opting for cosmetic procedures to look attractive in order to get lucrative jobs, best possible marriage partners and primarily get rid of any deformity that they feel impacts their self confidence and self-esteem. Moreover, traditionally, men and women in their late 20s and early 30s were the key clients of cosmetic surgeons. However, a new trend has emerged where teenagers are approaching cosmetic/ aesthetic surgeons to get some cosmetic procedure done.

Akumentis Healthcare awarded as “India’s Most Watched Company of the Year 2015” at Pharma Leaders Annual Meet 2015

Akumentis Healthcare awarded as “India’s Most Watched Company of the Year 2015” at Pharma Leaders Annual Meet 2015

Akumentis Healthcare recognised at Pharma Leaders Super Brand Awards 2015. The Mid Sized Pharma Major received the credible jury award in the category of India’s Most Watched Company of the Year 2015 at the historic 8th Annual Pharmaceutical Leadership Summit & Pharma Leaders Super Brand Awards 2015 in Mumbai on 30th December 2015

 


 

 

Mumbai based Akumentis Healthcare Limited which shot to limelight in demonstrating top achievement in the fiercely competitive branded formulation market in india to reach the magic figure of 100 crores during the first year of its operation received yet another feather in its cap at the prestigious 8th edition of pharmaceutical leaderhip summit & Pharma Leaders Business leadership Awards 2015 held recently in mumbai in india on 30th December 2015. Akumentis Healthcare Limited was unanimously voted by the jury members of the Network 7 Media Group as Most Watched Company of the Year 2015 for its consistent performance, medical innovations & sustained campaigns for CME’s to the medical profession.

In a letter addressed to Dr. Rajaram Samant, CEO & Chief Mentor of Akumentis Healthcare Limited, the Selection committee wrote “your performance in the indian pharmaceutical market space despite fierce competition has been remarkable resulting in making entry into top 100 companies in india. Your penetration into the domestic market & building long term relationships with the medical professionals & winning their confidence has been exemplary and no wonder and no wonder, your market dominance continues in the areas of Infertility Management, Obstetrics & Gynaecology,Osteoporosis management,Pain & Inflammation Management,Paediatrics & Geriatrics Nutrition,Gastroenterology,Ophthalmologyetc. Further, growth equity investment firm Sequoia Capital desire to invest Rs 125 crore (approximately $19 million) will result in further growth & new product launches.Akumentis  has been the unanimous choice as the India’s Most Watched Company of the year 2015 2015  at Pharma Leaders Power Brand Award 2015 at the much awaited 8th Annual Pharmaceutical Leadership Summit & Pharma Leaders Business Leadership Awards 2015 hosted by Pharma Leaders, Asia’s Most Analytical News Media in Healthcare Communications in association with the Ministry of Health & Family Affairs & Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India in the commercial capital of Mumbai on Wednesday,30th December 2015 at the Chancellor Suite of Hotel Hilton Mumbai International Airport, India. More than 300 Industry Leaders, Policy Makers, Medical Professionals, Scientists, Bureaucrats & Diplomats assembled to debate on an aptly theme Pharma Leaders 2015 – Brand India Winning. The Board Members further mentioned “You may be wondering how we chose you. The answer is that we sent out a team of Pharma Leaders analysts and industry experts on a global hunt for companies achieving dual excellence in two critical areas: Customer Value and Growth Success. Put another way, we were searching for companies that not only had a vision for a high-quality total customer experience, but used those insights to achieve growth above the industry average. We asked our global network of consultants and analysts to monitor, screen, and analyze creative practices within their regions. We spoke to industry peers. We vetted our findings with an independent board of directors. At the end of our process, one company stood out from the rest, and that company was yours”.To be a Winner in the prestigious title like  “India’s Most Watched Company of the year 2015” would never be an easy task, but it is one made even difficult due to today’s fierce competitive intensity, customer volatility & economic uncertainty – not to mention the difficulty of innovating in an environment of escalating challenges to intellectual property. In totality, you have distinctively stood apart from others, thus, your receipt of this award & recognition signifies your remarkable & outstanding achievement. Pharma Leaders Juries strongly believe that such an achievement should be acknowledged & celebrated. We are confident that your receipt of this recognition is the result of many factors ( Employees, Scientists, Customers,& investors) & years of hard work. We are always amazed by the success stories I hear about Indian pharmaceutical Companies, and Akumentis Healthcare is no exception. What began as an enterprise in  2010  with a modest beginning at its headquarter in Mumbai and has grown into one of the top pharmaceutical corporate in the country, has now  blossomed into a formidable power house in pharmaceutical business in india & aiming to be the global player by 2017 under your dynamic leadership. Your performance under tough conditions stands out to be the most watched company in 2015. This is an outstanding growth record in indian pharma space where the indian pharmaceuticals market recorded a CAGR of 12.79 per cent in 2015 from US$ 6 billion in 2005, and is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020 & By 2020, india is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size & the biggest advantage is that India’s cost of production is significantly lower than that of the US and almost half of that of Europe. It gives a competitive edge to India over others.Clearly & Undoubtedly, Your Firm’s accomplishments have infused the pharmaceutical industry with Innovative & path-breaking products, and your success has helped fuel our country’s economy. I appreciate the dedication & innovative spirit of your leadership, and I applaud his continued commitment to improve the healthcare standards, quality & magnitude of reach of today & tomorrow’s Healthcare”.

 


 

 

  • Akumentis was awarded as ‘Emerging Company of the Year 2012’ by Ministry of Commerce.
  • Dr Rajaram Samant, CEO and Chief Mentor, was awarded as ‘Dynamic Entrepreneur of the Year 2012’ by his Excellency K. Shankaranarayanan, Hon.Governor of Maharashtra.
  • Samant was awarded as ‘First Generation Entrepreneur of The Year’
  • Akumentis entered the Top 65 list in its first year with turnover in excess of Rs 90 crores.
  • Akumentis further sharpened its focus on its core areas and entered cosmetology in the third year.
  • Entered Top 50 ranks within three years of its launch in India
  • Akumentis voted as India’s Most Watched Pharma Company of the Year 2015 at Joint Pharma Leaders & Ministry of Health & Family Affairs, Government of India

 

Overview

Founded in 2010″Akumentis Healthcare Pvt. Ltd. is India’s most upcoming & fastest growing Pharmaceutical Company entering top 65 companies in India in the very first year of its launch. “The company is backed by a network of 7 world class manufacturing units and R & D facilities across India. The manufacturing facility is the one of the largest in Asia with WHO, GMP, ISO 9001, ISO 14001 certifications & USFDA and UKMHRA approvable. “The Company have more than 100 innovative products in the pipeline across 8-10 therapeutic segments. A healthy work environment is the pillar of existence of an organisation and a friendly culture motivates employees to associate better with a company. Akumentis believes in core values like innovation, hard work, honesty, deepest care with passion, tolerance for honest mistakes and organisation growth and development of its employees.

In Samant’s words, “Ours is an innovation driven culture, wherein we are introducing innovative products (first time in India)- this helps our field force get maximum time with doctors and is directly proportional to business and success- this is the biggest motivator to our employees. And we have special programmes to identify and help them build on their personal dreams.”

The Company is currently operating in the following segments

  • Infertility management
  • Obstetrics & Gynaecology
  • Osteoporosis management
  • Pain & Inflammation Management
  • Paediatrics & geriatrics nutrition
  • Gastroenterology
  • Ophthalmology
  • Dentist
  • Acute & Chronic infection

 

About Pharma Leaders Awards

Pharma Leaders Awards has an established record of leadership in research, innovation and in ongoing improvements to health services through strong healthcare leadership. These Awards seek to recognise outstanding health leadership by an individual or team resulting in positive change across the global health system. Pharma Leaders Awards attempt to  recognize outstanding individual and team contributions across priority areas selected by the Pharmaleaders Jury. The Pharma leaders  Award recognises outstanding leadership, by an individual or Companies for a distinctive recognition in a clear exhibition of top performances in various verticals. The Pharma Leaders Awards has also committed to being the premier award show in  healthcare that sets standards, through industry leaders as judges and navigators as well as critics who know good from great and brilliant from best. Through the Pharma Leaders Awards, we are now seeing outstanding work across the board globally, not only in the conventional media but in new media, digital, viral integrated and interactive. This is what great shows do. Celebrate, recognise and encourage us all to do better is the guiding spirit.


 

 

Jenburkt Pharmaceuticals voted by the Network 7 Media Group as “India’s Most Promising & Valuable Company 2015”

Jenburkt Pharmaceuticals voted by the Network 7 Media Group as “India’s Most Promising & Valuable Company 2015”

Jenburkt Pharmaceuticals selected by the Jury of Pharma Leaders Board for consistent performance at Pharma Leaders Super Brand Awards 2015 Annual Ceremony

Jenburkt Pharmaceuticals, India’s fastest growing pharmaceutical company having dominant presence in the key therapeutic segments with ethical marketing network received the rare distinction at the prestigious Pharma Leaders Platform in its 2015 Annual Award Editions as “India’s Most Promising & Valuable Company 2015” at the 8th Annual Pharmaceutical Leadership Summit & Pharma leaders Business Leadership Awards 2015 on Wednesday, 30th December at  Hotel Hilton Mumbai International Airport, Mumbai, India where more than 300 power packed business tycoons, diplomats,healthcare leaders had assempled to be part of the historic debate on PHARMA LEADERS 2015 –  BRAND INDIA WINNING.

The Award Trophy & Certificate of Excellence was presented in a glittering award ceremony marked by the presence of Who’s & Who’s of the Indian Pharmaceutical Industry. Mr. Louis Banks who has often  been referred to as the Godfather of Indian Jazz & the iconic music composer was the Chief Guest of the evening conferred the awards with the presence of Mr.Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders Group, asia’s most analytical news media in healthcare communications.

In a letter addressed to Mr. Ashish Bhuta, CMD, Jenburkt Pharmaceuticals Limited, The selection committee outlined the process of selection as What began as an enterprise in  1985 with a single manufacturing facility at has grown into one of the biggest pharmaceutical corporate in the country, has now  blossomed into a formidable power house in pharmaceutical business in india & aiming at  much more bigger space under your dynamic leadership. Your performance under tough conditions stands out to be the most watched company in 2015. This is an outstanding growth record in indian pharma space where the indian pharmaceuticals market recorded a CAGR of 12.79 per cent in 2015 from US$ 6 billion in 2005, and is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020 & By 2020, india is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size & the biggest advantage is that India’s cost of production is significantly lower than that of the US and almost half of that of Europe. It gives a competitive edge to India over others.

 


 

Founded in 1985, Jenburkt Pharmaceuticals is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Jenburkt is a public limited company, with its stock listed on the Bombay Stock Exchange. Jenburkt’s head quarters is located in Mumbai, from where its entire operations are handled. Jenburkt Pharmaceuticals Ltd. manufactures and markets pharmaceutical formulations in India and internationally. It offers prescription medicines in various therapeutic areas, such as anthelmintic, anti-arthritic, antibiotics, antidiabetic, anti-hypertensive, anti-inflammory analgesic, anti-malarial, anti-osteoporotic, anti-ulcerants, aphrodisiac, dermatological, gastrointenstinal, hematinics, neuropathy, and protein preparation, as well as anti-cough, cold, and allergy. The company was founded in 1985 and is based in Mumbai, India.

Strong Domestic Operations:

Jenburkt Pharma has a strong committed team of more than 575 sales force across India, Jenburkt promotes all its 85 brands ethically across 75,000 doctors and 50,000 chemists regularly. Backing the strong force company has more than 1000 stockists and 25 superstockists. Jenburkt also caters to large Government, Semi-Government Institutions, Missionary Hospitals, Public Sector Enterprises, etc.

Growing International Exports:

Currently, Jenburkt’s products are being exported to 15 countries globally with a clear focus to expand on a yearly basis. Also Jenburkt is open to partnering foreign pharmaceutical firms to market their pharmaceutical products in India; Company is also in search of a capable partner to market their pharmaceutical products across the globe through which they can improve on their exports sales which constitutes small proportion of total sales.

jenburkt

Strengthening the Brand:

Company is focused on strengthening their brands in their respective segments during the last year. There is a growing trend of competition from regional companies who operate either in a few districts or in a few states in India. This is apart from the competition from large organizations operating in India. Neuropathy detection camps and bone densitometry camps were carried out in various parts of the country for detection of neuropathy and osteoporosis.. The strategy of Company is to focus on long term therapies in acute and chronic ailments, by moving up the value chain continuously. As a result, a few of the Company’s brands are the preferred choice in certain segments. Company has some strong brand like CARTI SAFE FORTE (Anti Arithritic) , POWERGESIC Tablets (Anti Inflammory Analogesic).They rank among the top five in those segments.

Quality Portfolio of Products:

Jenburkt has good health through quality products that include prescription and over-the-counter drugs. Their prescription medicines span across various therapeutic areas such as anti-arthritic, antimalarials, anti-osteoporotic, antibiotics, antidiabetics and anti-inflammatory drugs and more. Hence Company has good quality of products in their portfolio.

Strong Manufacturing Facilities:

Company has the state-of-the-art manufacturing plant at Sihor-Gujarat, in India. The plant is modern and well-equipped with spacious operational areas having adequate capacities for manufacturing world-class pharmaceutical and healthcare products. Company’s plant is approved as per W.H.O Guidelines with current G.M.P requirements, apart from approvals from various countries. Furthering the development of formulations, Jenburkt has a Research & Development unit duly approved by the Ministry of Science & Technology, Government of India. Hence company has strong manufacturing facilities to cater both domestic and international market. Also Jenburkt has a progressive lineage of manufacturing high quality formulations backed by a strong Research & Development, Regulatory and global marketing team. The big thrust of Jenburkt’s strategy is to focus on creating a new category in the Indian and the International pharmaceutical market vis a vis.

Recent R&D Activities:

Recently company undertook commercial scale manufacturing of Frendacid, an antacid and antiflatulance for export market. Also Company continue to work towards formulating new and existing molecules for domestic and international market for efficient and cost saving drug delivery systems. Hence company is in continuous process of improving on its product portfolio.

Iconic Music Composer Louiz Banks awards Molecule Communications Most Promising & Valuable Communication Agency 2015

Iconic Music Composer Louiz Banks awards Molecule Communications Most Promising & Valuable Communication Agency 2015

Molecule Communications recognised at Pharma Leaders Power Brand Awards 2015 for redefining the communication & Media segments for path-breaking initiatives & innovative campaigns. 

Molecule Communications, a 360 degree media solutions and content company, one of the few which is adept in strategic media relations for brand building with operations pan India and New York providing services and solutions on all platforms of media, from print to electronic received a rare recognition at the asia’s biggest healthcare leadership meet at the  8th Annual Pharmaceutical Leadership Summit & Pharma leaders Business Leadership Awards 2015. Ms. Kiren Shrivastav, CEO & Founder of Molecule Communications received the prestigious & coveted Award & Certificate of Excellence from the hands of India’s top Music Composer & a living legend Louiz Banks with the presence of Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders, a leading media title in healthcare journalism.

Speaking to the media on receiving the recognition at the top healthcare platform, Kiren Shrivastav, CEO & Founder of Molecule Communications said “It indeed is a great privilege and honor to be receiving the award where the top healthcare leaders of the country are present & this award reflects our efforts to initiate innovative & creative communication plans & campaigns that we have served to our clients. We at Molecule want to bridge the gap between global entertainment industries, create an essential space for different worlds to meet and collaborate; encourage interactions between industries and the public forum. We foster valuable relationships between people from various sectors of entertainment industry including filmmaking and music. By producing panels and workshops featuring a diversity of highly-respected, successful professionals, Molecule Communications has quickly become an invaluable source for insights into emerging global markets for filmmaking and music.We have clients from various sectors like sports, corporate, entertainment, TV, cinema, music and fashion”.

Pharmaleaders Power Brand Awards are the most prestigious annual industry awards, recognized annually that acknowledge and honor individuals and organizations for their remarkable accomplishments. These set of awards are widely acclaimed in the industry circle as   fitting tribute to those individuals and companies that have gone the extra mile to advance the excellence in healthcare through best practices, initiatives,dynamism,drive & towering  leadership. Pharmaleaders Business Leadership Awards are the premier largest business and technology leadership awards program in the sub continent , covering the set of prestigious awards spanning from biotech to Healthcare to CEO awards. Pharma Leaders Power Brand Awards are conferred to those Companies & Individuals who exhibit rare display of innovation for Outstanding Academic & Professional Leadership to individuals & Companies. This top recognition symbolizes the best out of best from chosen few.

Kiren Shrivastav, the brain behind the communication machine of the award winning Agency, Molecule Communications,  is the key business strategist and a versatile media expert. After garnering enough experience and knowledge in event, films and media management, Kiren displayed rare business acumen by setting up this boutique media services company in 2007. She is best at people management which allows her impeccable project supervision and execution. She spearheads the functioning and growth of Molecule group. Being young and open to new radical ideas, Kiren takes an open minded approach to work along with calculated risks. She has a passion for music and dancing that makes her cheerful that she is. Her clarity of thought combined with a very base level understanding of the lowest common denominator allows her to understand the needs of the clients and the employees. Like a magician she turns ideas into reality. Her dream is to make this company known not just for its work but for its approach and professionalism. She aims at getting the IPO of Molecule Group which has marketing communications, media relations, motion pictures and television.